本研究针对重复前列腺活检中PI-RADS 3病变的诊断挑战，通过回顾性分析684例患者数据，发现PI-RADS 3是阴性活检的独立预测因子（OR 0.582），而PSA密度（PSAD）在PI-RADS 4-5病变中具有显著风险分层价值（62.4% vs 33.8%），在PI-RADS 3中则差异有限（20.7% vs 16.2%）。该研究为 ...

本研究针对基于白人群体开发的PI-RADS评分系统在非白人群体中的适用性问题，通过分析PREVENT试验中665例PI-RADS 3-5分患者的活检数据，发现黑人男性PI-RADS 3分病灶的临床显著前列腺癌(csPCa)检出率较白人高20%(OR 1.20, P=0.004)，而亚洲男性PI-RADS 3分病灶均未检出癌症。

New evidence compares micro-ultrasound and MRI fusion biopsy for detecting clinically significant prostate cancer. Find out ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

Temporal trends and factors associated with overuse of neoadjuvant androgen deprivation therapy in low and very low risk prostate cancer. Changes in multiparametric prostate MRI and immune subsets in ...

The use of multiparametric (MP) MRI has improved the detection of clinically important prostate cancers and has cut down on the detection of indolent cancers. However, new findings from a study ...